Literature DB >> 27578012

Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.

Li-Na Lu1, Zhong-Ming Qian2, Ka-Chun Wu1, Wing-Ho Yung1, Ya Ke3.   

Abstract

Iron accumulates progressively in the brain with age; however, the cause is unknown. We hypothesized that iron accumulation may be associated with the age-induced changes in the expression of iron metabolism proteins in the brain. Here, we systematically investigated iron content and the expression of two major iron importers, transferrin receptor 1 (TfR1) and divalent metal transporter (DMT1), two iron exporters, ferroportin 1 (Fpn1) and ceruloplasmin (CP), and hepcidin, along with the pathological hallmarks of Parkinson's (PD) and Alzheimer's diseases (AD) in the brain of young (3 months), adult (12 months), and aged (24 months) rats. We demonstrated that age has a region-specific effect on iron transport proteins along with iron content in the cortex, striatum, hippocampus, and substantia nigra. We also found an age-dependent increase in hyperphosphorylated tau, total beta-amyloid, and neurotoxic oligomeric aggregates in the cortex and hippocampus as well as an increase in α-synuclein and a decrease in tyrosine hydroxylase positive neurons in the substantia nigra. Our findings suggest that the age-dependent increase in brain iron may be partly due to the age-induced increase in DMT1 expression, rather than TfR1 and Fpn1 expression, and also imply that the increased brain iron is associated with expression of the pathological hallmarks of AD and PD.

Entities:  

Keywords:  Age; Beta-amyloid; Hepcidin; Hyperphosphorylated tau; Iron; Iron uptake and release proteins; α-Synuclein

Mesh:

Substances:

Year:  2016        PMID: 27578012     DOI: 10.1007/s12035-016-0067-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  72 in total

Review 1.  Brain iron and neurological disorders.

Authors:  Z Qian; Q Wang; Y Pu
Journal:  Chin Med J (Engl)       Date:  1997-06       Impact factor: 2.628

2.  Distribution of ferroportin1 protein in different regions of developing rat brain.

Authors:  Dai He Jiang; Ya Ke; Yan Zhong Cheng; Kwok Pin Ho; Zhong Ming Qian
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

3.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.

Authors:  Lisa Mosconi; Lidia Glodzik; Rachel Mistur; Pauline McHugh; Kenneth E Rich; Elizabeth Javier; Schantel Williams; Elizabeth Pirraglia; Susan De Santi; Pankaj D Mehta; Raymond Zinkowski; Kaj Blennow; Domenico Pratico; Mony J de Leon
Journal:  Biol Psychiatry       Date:  2010-11-15       Impact factor: 13.382

4.  Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys.

Authors:  Wayne A Cass; Richard Grondin; Anders H Andersen; Zhiming Zhang; Peter A Hardy; Lindsay K Hussey-Andersen; William S Rayens; Greg A Gerhardt; Don M Gash
Journal:  Neurobiol Aging       Date:  2006-01-26       Impact factor: 4.673

5.  Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

Authors:  M Baldereschi; A Di Carlo; W A Rocca; P Vanni; S Maggi; E Perissinotto; F Grigoletto; L Amaducci; D Inzitari
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

6.  Increasing striatal iron content associated with normal aging.

Authors:  W R Martin; F Q Ye; P S Allen
Journal:  Mov Disord       Date:  1998-03       Impact factor: 10.338

7.  Iron, transferrin, and ferritin in the rat brain during development and aging.

Authors:  A J Roskams; J R Connor
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

8.  Regulation of iron-related molecules in the rat hippocampus: sex- and age-associated differences.

Authors:  Srinivasarao Thulluri; Miaozong Wu; Eric R Blough; Nandini D P K Manne; Ashley B Litchfield; Bin Wang
Journal:  Ann Clin Lab Sci       Date:  2012       Impact factor: 1.256

9.  The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.

Authors:  Xiao Hu Ge; Qin Wang; Zhong Ming Qian; Li Zhu; Fang Du; Wing Ho Yung; Lei Yang; Ya Ke
Journal:  J Nutr Biochem       Date:  2008-11-22       Impact factor: 6.048

Review 10.  Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.

Authors:  Oddvar Myhre; Hans Utkilen; Nur Duale; Gunnar Brunborg; Tim Hofer
Journal:  Oxid Med Cell Longev       Date:  2013-04-17       Impact factor: 6.543

View more
  19 in total

1.  Different Characteristics of Hepcidin Expression in IL-6+/+ and IL-6-/- Neurons and Astrocytes Treated with Lipopolysaccharides.

Authors:  Juan Ma; Fa-Li Zhang; Gan Zhou; Yu-Xin Bao; Yuan Shen; Zhong-Ming Qian
Journal:  Neurochem Res       Date:  2018-06-19       Impact factor: 3.996

2.  Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice.

Authors:  Jie Zheng; Jiao-Jiao Wang; Hui-Min Ma; Meng-Qi Shen; Zhong-Ming Qian; Yu-Xin Bao
Journal:  Redox Rep       Date:  2022-12       Impact factor: 5.696

3.  Treadmill Exercise Alleviates Brain Iron Dyshomeostasis Accelerating Neuronal Amyloid-β Production, Neuronal Cell Death, and Cognitive Impairment in Transgenic Mice Model of Alzheimer's Disease.

Authors:  Dong-Hun Choi; Ki-Chun Kwon; Dong-Joo Hwang; Jung-Hoon Koo; Hyun-Seob Um; Hong-Sun Song; Ji-Sun Kim; Yongchul Jang; Joon-Yong Cho
Journal:  Mol Neurobiol       Date:  2021-02-28       Impact factor: 5.590

4.  Dopamine-related striatal neurophysiology is associated with specialization of frontostriatal reward circuitry through adolescence.

Authors:  Ashley C Parr; Finnegan Calabro; Bart Larsen; Brenden Tervo-Clemmens; Samuel Elliot; Will Foran; Valur Olafsson; Beatriz Luna
Journal:  Prog Neurobiol       Date:  2021-03-02       Impact factor: 10.885

Review 5.  Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.

Authors:  Mattia Toni; Maria L Massimino; Agnese De Mario; Elisa Angiulli; Enzo Spisni
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

Review 6.  New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.

Authors:  Huamin Xu; Hong Jiang; Junxia Xie
Journal:  Front Mol Neurosci       Date:  2017-03-16       Impact factor: 5.639

7.  Impairment of Hepcidin Upregulation by Lipopolysaccharide in the Interleukin-6 Knockout Mouse Brain.

Authors:  Fa-Li Zhang; Hui-Min Hou; Zhi-Nan Yin; Lan Chang; Fe-Mi Li; Y-J Chen; Ya Ke; Zhong-Ming Qian
Journal:  Front Mol Neurosci       Date:  2017-11-07       Impact factor: 5.639

8.  Aging and Progression of Beta-Amyloid Pathology in Alzheimer's Disease Correlates with Microglial Heme-Oxygenase-1 Overexpression.

Authors:  Cristina Fernández-Mendívil; Miguel A Arreola; Lindsay A Hohsfield; Kim N Green; Manuela G Lopez
Journal:  Antioxidants (Basel)       Date:  2020-07-21

Review 9.  Hepcidin, an emerging and important player in brain iron homeostasis.

Authors:  Driton Vela
Journal:  J Transl Med       Date:  2018-02-07       Impact factor: 5.531

Review 10.  The Dual Role of Hepcidin in Brain Iron Load and Inflammation.

Authors:  Driton Vela
Journal:  Front Neurosci       Date:  2018-10-15       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.